Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zinaida Good

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cancer Immunology Research|October 31, 2023
Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology SymposiumChristopher Alvarez-Breckenridge, Kristin G Anderson, Ana Luisa Correia, et al.
Science (New York, N.Y.)|April 2, 2021
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodelingEvan W Weber, Kevin R Parker, Elena Sotillo, et al.
Cancer Discovery|January 8, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCLYi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton, et al.
Blood Advances|March 18, 2024
CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicityMark P Hamilton, Erin Craig, Cesar Gentille Sanchez, et al.
Nature Medicine|September 13, 2022
Post-infusion CAR T<sub>Reg</sub> cells identify patients resistant to CD19-CAR therapyZinaida Good, Jay Y Spiegel, Bita Sahaf, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Nature|May 15, 2024
Engineered CD47 protects T cells for enhanced antitumour immunitySean A Yamada-Hunter, Johanna Theruvath, Brianna J McIntosh, et al.
Research Square|November 24, 2025
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopeniasMark P Hamilton, Nick Phillips, Troy Noordenbos, et al.
Nature Biomedical Engineering|March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancerGregory M Chen, Ankita Jain, David T Gering, et al.
Nature|February 7, 2022
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomasRobbie G Majzner, Sneha Ramakrishna, Kristen W Yeom, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Immunology Research|October 31, 2023
Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology SymposiumChristopher Alvarez-Breckenridge, Kristin G Anderson, Ana Luisa Correia, et al.
Science (New York, N.Y.)|April 2, 2021
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodelingEvan W Weber, Kevin R Parker, Elena Sotillo, et al.
Cancer Discovery|January 8, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCLYi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton, et al.
Blood Advances|March 18, 2024
CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicityMark P Hamilton, Erin Craig, Cesar Gentille Sanchez, et al.
Nature Medicine|September 13, 2022
Post-infusion CAR T<sub>Reg</sub> cells identify patients resistant to CD19-CAR therapyZinaida Good, Jay Y Spiegel, Bita Sahaf, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Nature|May 15, 2024
Engineered CD47 protects T cells for enhanced antitumour immunitySean A Yamada-Hunter, Johanna Theruvath, Brianna J McIntosh, et al.
Research Square|November 24, 2025
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopeniasMark P Hamilton, Nick Phillips, Troy Noordenbos, et al.
Nature Biomedical Engineering|March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancerGregory M Chen, Ankita Jain, David T Gering, et al.
Nature|February 7, 2022
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomasRobbie G Majzner, Sneha Ramakrishna, Kristen W Yeom, et al.
Pageof 4